Allurion Technologies, Inc. Common Stock (ALUR)

Competitors to Allurion Technologies, Inc. Common Stock (ALUR)

Apollo Endosurgery

Apollo Endosurgery offers a suite of products for weight management, including the OverStitch endoscopic suturing system and their intragastric balloon. They compete with Allurion in the non-surgical weight loss category, but they are known for their surgical options. Apollo's advanced procedural solutions and clinical data may offer competitive advantages in more invasive intervention settings, while Allurion focuses on non-invasive therapies.

Bariatric Innovations

Bariatric Innovations specializes in providing non-surgical weight loss solutions, focusing on innovative devices like intragastric balloons. They compete with Allurion by targeting the same market of minimally invasive weight loss therapies. Both companies emphasize safety and effectiveness, but Bariatric Innovations has established partnerships in several regions, which could provide them with a broader market reach.

Medtronic plc 

Medtronic is a global leader in medical technology and offers a range of obesity and weight management solutions alongside its advanced gastroenterology devices. They compete with Allurion by providing more comprehensive solutions, including surgical devices. Medtronic's extensive resources and established reputation lend them a competitive advantage, particularly in securing partnerships with healthcare providers.

Obalon Therapeutics

Obalon Therapeutics focuses on its unique intragastric balloon system designed to aid in weight loss without requiring surgery. They directly compete with Allurion's Elipse Balloon system, which also serves similar purposes. However, Obalon faces challenges as they have had to reduce their spending and pivot their business model, which has affected their market presence, giving Allurion an edge in innovation and market engagement.